The global demand for Blood Coagulants Market is presumed to reach the market size of nearly USD 12.51 Billion by 2032 from USD 6.4 Billion in 2023 with a CAGR of 7.73% under the study period 2024-2032.
Blood coagulants are substances that promote blood clotting, essential for stopping bleeding. They function by accelerating the conversion of fibrinogen to fibrin, forming a stable blood clot. Commonly used in surgeries and trauma care, these agents, such as thrombin and fibrinogen, can be natural or synthetic, like tranexamic acid. They are crucial in managing conditions like hemophilia, where there is a dysfunction in the blood's clotting ability, and in situations requiring rapid hemostasis. It must be used carefully to avoid complications such as excessive clotting, which can lead to conditions like thrombosis.
The demand and growth of the blood coagulants market are propelled by the growing prevalence of cardiovascular diseases and bleeding disorders, such as hemophilia, which necessitates using blood coagulants to manage and treat these conditions effectively. Additionally, the increasing number of surgical procedures globally is boosting market growth to ensure proper hemostasis during and after surgeries. The growing age of the population is another significant factor, as elderly individuals are more prone to conditions requiring these coagulants. Technological advancements in the development of novel and more efficient coagulants are also contributing to market growth. These innovations offer improved safety profiles and better patient outcomes, thus driving their adoption in clinical settings.
Furthermore, increased awareness and diagnosis of bleeding disorders are leading to a higher demand for these coagulants. Pharmaceutical companies' growing investment in research and development to create next-generation blood coagulants is expected to propel market expansion further. Lastly, expanding healthcare infrastructure in emerging economies provides new market opportunities, as improved healthcare services and facilities increase the accessibility and availability of these critical treatments. However, the high cost of advanced treatments and potential side effects may challenge market growth in the coming years.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Blood Coagulants. The growth and trends of Blood Coagulants industry provide a holistic approach to this study.
This section of the Blood Coagulants market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Type
By Application
This section covers the regional outlook, which accentuates current and future demand for the Blood Coagulants market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Blood Coagulants market include Pfizer, Bayer, Novo Nordisk, Shire, SOBI, Octapharma, CSL. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
1. PREFACE
1.1. Report Description
1.1.1 Objective
1.1.2 Target Audience
1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1 Market Research Process
1.3.2 Market Research Methodology
2. EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3. BLOOD COAGULANTS – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Type
3.7.2 Market Attractiveness Analysis By Application
3.7.3 Market Attractiveness Analysis By Region
4. VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1 List of Raw Materials
4.2.2 Raw Material Manufactures List
4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1 Direct Marketing
4.4.2 Indirect Marketing
4.4.3 Marketing Channel Development Trend
5. GLOBAL BLOOD COAGULANTS MARKET ANALYSIS BY TYPE
5.1. Overview By Type
5.2. Historical and Forecast Data Analysis By Type
5.3. Recombinant Coagulation Factor Historic and Forecast Sales By Regions
5.4. Plasma Coagulation Factor Historic and Forecast Sales By Regions
6. GLOBAL BLOOD COAGULANTS MARKET ANALYSIS BY APPLICATION
6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Hospital Historic and Forecast Sales By Regions
6.4. Pharmacy Historic and Forecast Sales By Regions
6.5. Other Historic and Forecast Sales By Regions
7. GLOBAL BLOOD COAGULANTS MARKET ANALYSIS BY GEOGRAPHY
7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
&n...
